Bassetti, Matteo http://orcid.org/0000-0002-2004-3724
Giacobbe, Daniele R.
Vena, Antonio
Trucchi, Cecilia
Ansaldi, Filippo
Antonelli, Massimo
Adamkova, Vaclava
Alicino, Cristiano
Almyroudi, Maria-Panagiota
Atchade, Enora
Azzini, Anna M.
Carannante, Novella
Carnelutti, Alessia
Corcione, Silvia
Cortegiani, Andrea
Dimopoulos, George
Dubler, Simon
García-Garmendia, José L.
Girardis, Massimo
Cornely, Oliver A.
Ianniruberto, Stefano
Kullberg, Bart Jan
Lagrou, Katrien
Le Bihan, Clement
Luzzati, Roberto
Malbrain, Manu L. N. G.
Merelli, Maria
Marques, Ana J.
Martin-Loeches, Ignacio
Mesini, Alessio
Paiva, José-Artur
Peghin, Maddalena
Raineri, Santi Maurizio
Rautemaa-Richardson, Riina
Schouten, Jeroen
Brugnaro, Pierluigi
Spapen, Herbert
Tasioudis, Polychronis
Timsit, Jean-François
Tisa, Valentino
Tumbarello, Mario
van den Berg, Charlotte H. S. B.
Veber, Benoit
Venditti, Mario
Voiriot, Guillaume
Wauters, Joost
Montravers, Philippe
Article History
Received: 5 April 2019
Accepted: 28 May 2019
First Online: 14 June 2019
Ethics approval and consent to participate
: Specific informed consent for this study was not necessary because of the retrospective nature of the analyses. The study was approved by the Ethics Committee of the coordinating center (Regional Ethics Committee of Friuli-Venezia-Giulia Region, parere CEUR-2017-Os-033-ASUIUD).
: Not applicable.
: Outside the submitted work, MB reports grants and personal fees from Pfizer, grants and personal fees from MSD, grants and personal fees from Cidara, personal fees from Astellas, and personal fees from Gilead. DRG reports personal fees from Stepstone Pharma GmbH and an unconditioned grant from MSD Italia. GD reports personal fees from Pfizer, Infectopharm, and EU/FP7/Magic Bullet and a grant for his institution from MSD. JLGG reports a formative grant from MSD, a formative grant from Fresenius, and payment for lecture from Astra Zeneca. BJK reports grants for his institution from Amplyx, Astellas, and Cidara. KL has received research grants from Gilead, MSD, and Pfizer; consultancy fees from Gilead, Pfizer, Abbott, MSD, and SMB Laboratoires Brussels; travel support from Pfizer, Gilead, and MSD; and speaker fees from Gilead, Roche, and Abbott. JFT has received grants for his institution from Pfizer and MSD and personal fees from BioMérieux and participated in advisory board for MSD, Bayer, 3 M, and Gilead. PM reports personal fees from Pfizer and MSD. The other authors declare that they have no competing interests.